Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Tables)

v3.24.1.1.u2
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Schedule of concentration of risk
           
    For the Year Ended March 31,  
    2024     2023  
Customer A     17%       11%  
Customer B     15%       16%  
Customer C     14%       18%  
Customer D     –*%       –*%  

 

The following table shows major customers accounts receivable balances as a percentage of net accounts receivables:

             
    March 31,  
    2024     2023  
Customer A     –*%       –*%  
Customer B     13%       22%  
Customer C     –*%       –*%  
Customer D     17%       21%  
Schedule of property and equipment estimated useful life
     
    Years  
Office equipment   3  
Manufacturing, lab and other equipment   5  
Furniture and fixtures   7  
Schedule of computation of earnings per share
           
    For the Year Ended March 31,  
(In thousands, except per share data)   2024     2023  
             
Net loss   $ (4,835 )   $ (5,151 )
                 
Weighted-average shares outstanding: basic and diluted     9,090       3,394  
                 
Net loss per share: basic and diluted   $ (0.53 )   $ (1.52 )
Schedule of antidilutive shares
           
    March 31,  
(In thousands)   2024     2023  
             
Common stock to be issued upon exercise of options     1,033       565  
Common stock to be issued upon exercise of warrants     –       104  
Common stock to be issued upon exercise of common stock units (1)     –       46  
      1,033       715  

  

(1) Consists of 30,668 restricted stock units and warrants to purchase 15,332 shares of common stock